362 related articles for article (PubMed ID: 16515974)
1. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?
Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H
J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974
[TBL] [Abstract][Full Text] [Related]
2. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
3. The value of a second transurethral resection for T1 bladder cancer.
Schwaibold HE; Sivalingam S; May F; Hartung R
BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
[TBL] [Abstract][Full Text] [Related]
4. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
Li LY; Yang M; Zhang HB; Su XK; Xu WF; Chen Y; Shen ZJ; Gao X
BJU Int; 2008 Aug; 102(5):566-71. PubMed ID: 18410436
[TBL] [Abstract][Full Text] [Related]
5. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
Herr HW; Donat SM; Dalbagni G
J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
[TBL] [Abstract][Full Text] [Related]
6. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
Brauers A; Buettner R; Jakse G
J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
8. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial.
Divrik RT; Sahin AF; Yildirim U; Altok M; Zorlu F
Eur Urol; 2010 Aug; 58(2):185-90. PubMed ID: 20303646
[TBL] [Abstract][Full Text] [Related]
9. A second-look TUR in T1 transitional cell carcinoma: why?
Jakse G; Algaba F; Malmström PU; Oosterlinck W
Eur Urol; 2004 May; 45(5):539-46; discussion 546. PubMed ID: 15082193
[TBL] [Abstract][Full Text] [Related]
10. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
[TBL] [Abstract][Full Text] [Related]
12. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
[TBL] [Abstract][Full Text] [Related]
13. Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor.
Lee SE; Jeong IG; Ku JH; Kwak C; Lee E; Jeong JS
Urology; 2004 May; 63(5):873-7; discussion 877. PubMed ID: 15134968
[TBL] [Abstract][Full Text] [Related]
14. Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer.
Naselli A; Introini C; Bertolotto F; Spina B; Puppo P
BJU Int; 2010 Jan; 105(2):208-11. PubMed ID: 19549255
[TBL] [Abstract][Full Text] [Related]
15. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy.
Dutta SC; Smith JA; Shappell SB; Coffey CS; Chang SS; Cookson MS
J Urol; 2001 Aug; 166(2):490-3. PubMed ID: 11458053
[TBL] [Abstract][Full Text] [Related]
16. [A clinical study of superficial bladder cancer with grade 3 components].
Iiyama T; Hariu K; Kawai M; Kamiyama Y; Okano Y; Shimizu H; Tomomasa H; Iizumi T; Yazaki T; Umeda T
Hinyokika Kiyo; 1998 Jun; 44(6):375-9. PubMed ID: 9719934
[TBL] [Abstract][Full Text] [Related]
17. Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists.
Zurkirchen MA; Sulser T; Gaspert A; Hauri D
Urol Int; 2004; 72(2):99-102. PubMed ID: 14963348
[TBL] [Abstract][Full Text] [Related]
18. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
Nielsen ME; Bastian PJ; Palapattu GS; Trock BJ; Schoenberg MP; Chan T; Rogers CG
Urology; 2007 Dec; 70(6):1091-5. PubMed ID: 18158024
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
20. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
